Sponsored

Technological advances are creating opportunities in the medical sector for private equity firms prepared to embrace innovation, say Baker McKenzie partners David Allen and Jane Hobson

Secondaries firm Pomona Capital celebrates its 25th anniversary this year. Chief executive and founder Michael Granoff discusses how the secondaries environment and Pomona have evolved and what he sees for the future

With high prices and fierce competition for assets, PwC Germany partner Dr Oliver Schulte Ladbeck, head of business development for PwC Europe Deals, considers whether GPs can sustain the current level of returns

Fund structuring is becoming ever more complex, driven by more stringent LP requirements, tighter regulation and increasingly global investment strategies, says Dirk Holz, director at RBC Investor and Treasury Services.

Some of Japan’s top private equity investors discuss an influx of foreign firms, increasing dry powder and more demanding LPs in this sponsored roundtable discussion.

For Japanese industrial businesses, a key growth driver is a revitalised management team, say J-STAR managing partner Kenichi Harada and principal Hiroaki Kiriseko

Partnering with company founders provides contrarian private equity buyers a rich seam of investments, says CLSA Capital Partners president Megumi Kiyozuka.

Domestic LPs are taking a more sophisticated approach to private equity, which involves the greater use of separate accounts, says Ryo Ohira, Neuberger Berman’s head of East Asia

Japanese private equity may have had a few false dawns in the past, but the market today is very different from that of just 10 years ago, says NSSK founding partner Jun Tsusaka

Institutional investors may be increasing their allocations to private equity, but GPs still need to take a thoughtful and strategic approach to the fundraising market, say FIRSTavenue executives Michael Henningsen and Colin Dinneen.